Prime Medicine, Inc. (NYSE:PRME) Given Consensus Rating of “Moderate Buy” by Analysts
Prime Medicine, Inc. (NYSE:PRME – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six ratings firms that are presently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month […]
More Stories
Guggenheim Capital LLC Has $246,000 Stock Holdings in Scorpio Tankers Inc. (NYSE:STNG)
Guggenheim Capital LLC trimmed its stake in shares of Scorpio Tankers Inc. (NYSE:STNG – Free Report) by 54.6% during the...
Amazon.com, Inc. (NASDAQ:AMZN) Shares Sold by Aufman Associates Inc
Aufman Associates Inc cut its holdings in Amazon.com, Inc. (NASDAQ:AMZN) by 9.6% during the fourth quarter, HoldingsChannel reports. The fund...
Raymond James Financial Inc. Makes New $2.99 Million Investment in Planet Fitness, Inc. (NYSE:PLNT)
Raymond James Financial Inc. purchased a new stake in shares of Planet Fitness, Inc. (NYSE:PLNT – Free Report) in the...
Tsai Capital Corp Sells 328 Shares of Amazon.com, Inc. (NASDAQ:AMZN)
Tsai Capital Corp trimmed its holdings in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 1.1% during the fourth quarter, according to...
Amazon.com, Inc. (NASDAQ:AMZN) Stake Lowered by Mechanics Financial Corp
Mechanics Financial Corp decreased its stake in Amazon.com, Inc. (NASDAQ:AMZN) by 0.9% during the 4th quarter, according to the company...
Eastman Chemical (NYSE:EMN) Lowered to Hold Rating by StockNews.com
StockNews.com downgraded shares of Eastman Chemical (NYSE:EMN – Free Report) from a buy rating to a hold rating in a...